TRISOMY-12 AND K-RAS-2 AMPLIFICATION IN HUMAN OVARIAN-TUMORS

被引：36
|
作者：
YANGFENG, TL
LI, SB
LEUNG, WY
CARCANGIU, ML
SCHWARTZ, PE
机构：
[1] NATL YANG MING MED COLL,VET GEN HOSP,DEPT OBSTET & GYNECOL,TAIPEI,TAIWAN
[2] YALE UNIV,SCH MED,DEPT PATHOL,NEW HAVEN,CT 06510
[3] YALE UNIV,SCH MED,DEPT OBSTET & GYNECOL,NEW HAVEN,CT 06510
来源：
INTERNATIONAL JOURNAL OF CANCER | 1991年 / 48卷 / 05期
关键词：
D O I：
10.1002/ijc.2910480508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cytogenetic analysis was performed on 11 benign and borderline ovarian tumors. Trisomy 12, identified as a sole abnormality in 6 tumors, is likely a specific karyotypic change in different benign and borderline tumors and may well be a primary chromosomal lesion in these tumors. The possible association between amplification of the proto-oncogene K-ras-2 which is located on chromosome 12 and trisomy 12 was investigated. DNA blotting analysis of 64 tumors indicates that trisomy 12 does not seem to be related to K-ras-2 amplification in ovarian tumors. K-ras-2 amplification was observed in 3 high-grade tumors from 3 patients with metastases.
引用
收藏
页码：678 / 681
页数：4
相关论文
共 50 条
  • [31] RESPONSE TO HUMAN CHORIONIC-GONADOTROPIN IN PATIENTS WITH OVARIAN-TUMORS
    SCIRPA, P
    MANGO, D
    LIBERATI, M
    MANNA, P
    TARTAGLIA, E
    RICCI, S
    IACONA, T
    MANCUSO, S
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1988, 67 (07) : 589 - 594
  • [32] AMYLASE FROM HUMAN SEROUS OVARIAN-TUMORS - PURIFICATION AND CHARACTERIZATION
    ZAKOWSKI, JJ
    GREGORY, MR
    BRUNS, DE
    CLINICAL CHEMISTRY, 1984, 30 (01) : 62 - 68
  • [33] INVITRO SENSITIVITY OF HUMAN OVARIAN-TUMORS TO CHEMOTHERAPEUTIC-AGENTS
    WILSON, AP
    NEAL, FE
    BRITISH JOURNAL OF CANCER, 1981, 44 (02) : 189 - 200
  • [34] K-RAS-2 GENOTYPING OF PANCREATIC ADENOCARCINOMA - CORRELATION WITH BIOLOGICAL BEHAVIOR
    FINKELSTEIN, SD
    BECICH, M
    PRZYGODZKI, R
    SAYEGH, R
    BAKKER, A
    SWALSKY, PA
    LABORATORY INVESTIGATION, 1994, 70 (01) : A60 - A60
  • [35] ESTABLISHMENT OF A NEW HUMAN B-CELL LINE (BONNA-12) WITH TRISOMY-9 AND TRISOMY-12 CHROMOSOMAL ABNORMALITY
    KLUINNELEMANS, JC
    WIENTJENS, GJHM
    JANSEN, JH
    LEUKEMIA, 1992, 6 (02) : 158 - 158
  • [36] ABNORMAL NEURAL FOLD DEVELOPMENT IN MOUSE TRISOMY-12 AND TRISOMY-14 .2. LM AND TEM
    MORRISSKAY, G
    PUTZ, B
    BRAIN RESEARCH BULLETIN, 1986, 16 (06) : 825 - 832
  • [37] GROWTH-BEHAVIOR OF 2 HUMAN OVARIAN-TUMORS IN NU-NU MICE
    SCHIEDER, K
    ROGAN, M
    BIEGLMAYER, C
    BREITENECKER, G
    JANISCH, H
    ZEITSCHRIFT FUR VERSUCHSTIERKUNDE, 1983, 25 (04): : 214 - 214
  • [38] DETERMINATION OF TUMOR AGGRESSIVENESS IN COLORECTAL-CANCER BY K-RAS-2 ANALYSIS
    FINKELSTEIN, SD
    SAYEGH, R
    BAKKER, A
    SWALSKY, P
    STEELE, GD
    FOSTER, RS
    MCKHANN, CF
    BUTSCH, DW
    ARCHIVES OF SURGERY, 1993, 128 (05) : 526 - 532
  • [39] K-RAS MUTATIONS IN OVARIAN MUCINOUS TUMORS
    PRAT, J
    CUATRECASAS, M
    MATIASGUIU, X
    VILLANUEVA, A
    CAPELLA, G
    LABORATORY INVESTIGATION, 1994, 70 (01) : A94 - A94
  • [40] PREDICTION OF COLORECTAL-CANCER AGGRESSIVENESS BY K-RAS-2 MUTATION GENOTYPING
    FINKELSTEIN, SD
    PRICOLO, VE
    BAKKER, A
    FINKELSTEIN, PA
    SAYEGH, R
    GASTROENTEROLOGY, 1993, 104 (04) : A399 - A399
12345